LUMIRIX LTD

Executive Summary

LUMIRIX LTD exhibits a robust financial foundation typical of a healthy start-up micro-entity, with strong liquidity and positive net assets. While profitability indicators are not yet available, the company's sound balance sheet and compliance record suggest a stable financial condition. Continued monitoring of cash flow and preparation for fuller financial disclosures will be essential as the business develops.

LUMIRIX LTD - Analysis Report

Company Number: 15549962

Analysis Date: 2025-07-20 16:49 UTC

Financial Health Assessment for LUMIRIX LTD

---

1. Financial Health Score: B

Explanation:
LUMIRIX LTD displays a sound financial footing for a newly incorporated micro-entity. The company shows strong net current assets (working capital), positive net assets, and no overdue filings—indicating good compliance and liquidity. However, as a start-up with just one full financial year, the absence of profit and loss data and limited operational history restrain a higher grade. Continued monitoring is advised.

---

2. Key Vital Signs

Metric	Value	Interpretation
Fixed Assets	£38,913	Indicates initial investment in long-term resources—healthy for a start-up.
Current Assets	£79,505	Solid short-term resources, including cash and receivables, to meet imminent obligations.
Current Liabilities	£6,497	Low short-term debt burden—manageable and indicates low immediate financial pressure.
Net Current Assets	£73,008	Strong positive working capital suggests healthy liquidity and ability to cover short-term debts.
Net Assets (Equity)	£111,921	Positive shareholder funds reflecting initial capital and retained earnings (if any).
Employees	3	Small, focused team consistent with micro-entity scale; manageable overhead.
Filing Status	Up to date	No overdue accounts or confirmation statements—good governance and compliance.

---

3. Diagnosis

LUMIRIX LTD is in the early stages of its lifecycle (incorporated March 2024) and has established a healthy financial baseline. The balance sheet shows "healthy cash flow" analogues, with current assets significantly exceeding current liabilities, indicating no liquidity distress. The company's net assets are positive and reflect the initial capital infusion, which acts like a "strong pulse" for financial stability.

The absence of profit and loss data in micro-entity filings means the "symptoms" of profitability or operational efficiency remain unobservable at this stage. However, the company's ability to maintain positive net current assets and comply with statutory filing deadlines reflects sound financial "vital signs."

The change in director and shareholding control within the first year suggests some governance adjustments, but both controlling individuals hold significant voting rights and influence, indicating stable leadership structure.

---

4. Recommendations

• Monitor Cash Flow Regularly: Maintain the current strong liquidity by closely tracking receivables and payables. This will help avoid any future "symptoms" of cash strain as operations scale.

• Prepare for P&L Disclosure: As the business grows, transitioning from micro-entity exemptions to fuller accounts with profit and loss statements will give better insight into profitability and operational health.

• Strengthen Governance: Ensure director roles and shareholder interests remain aligned to avoid internal conflict—this acts as a safeguard against "organizational stress."

• Plan for Growth Capital Needs: With fixed assets already invested, consider future capital requirements carefully to avoid over-leverage or cash flow bottlenecks.

• Maintain Compliance: Continue timely filings to avoid penalties and maintain the company’s reputation, a key "immune system" against regulatory risks.

---